Business
Nxera Pharma Establishes Metabolic Advisory Council to Advance Next-Generation Therapies for Obesity and Metabolic Disorders
Council brings together leading global scientific and clinical experts in metabolic diseases to guide development of Nxera’s expanding proprietary pipeline Tokyo, Japan and Cambridge, UK, 20 January 2026 – Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) today announces the formation of a Metabolic Advisory Council comprising world-leading industry experts to provide scientific, clinical, and strategic guidance as Nxera advances its rapidly growing pipeline of next-generation therapies t
About this update from Nxera Pharma Co., Ltd.
[{"type":"image","alt":"Nxera Pharma","displaySize":"","headline":null,"caption":"Nxera Pharma","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":101,"url":"https://media.zenfs.com/en/globenewswire.com/3c5c5d1f11d2ca9444665ce7b9191638"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/MMtO8FGLy1ULu25TBGkF3w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/3c5c5d1f11d2ca9444665ce7b9191638","width":300,"height":101}},"lazy":false},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Council brings together leading global scientific and clinical experts in metabolic diseases to guide development of Nxera’s expanding proprietary pipeline","length":155,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":155,"olType":false},{"type":"text","content":"Tokyo, Japan and Cambridge, UK, 20 January 2026 – Nxera Pharma Co. Ltd (“Nxera” or “the Company; TSE 4565) today announces the formation of a Metabolic Advisory Council comprising world-leading industry experts to provide scientific, clinical, and strategic guidance as Nxera advances its rapidly growing pipeline of next-generation therapies targeting obesity and metabolic disorders.","length":385,"tagName":"p"},{"type":"text","content":"The three founding members of the council are:","length":46,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Professor Sir Stephen O’Rahilly, University of Cambridge – globally recognized for pioneering research into the genetic and molecular mechanisms of metabolic diseases and a scientific leader whose discoveries have shaped modern obesity and diabetes treatment.","length":259,"tagName":"p"}]},{"val":[{"type":"text","content":"Professor Tricia Tan, Imperial College London – a distinguished clinician-scientist specializing in metabolic medicine and endocrinology, known for her translational research in appetite regulation and metabolic diagnostics.","length":224,"tagName":"p"}]},{"val":[{"type":"text","content":"Dr. Mads Tang-Christensen, Novo Nordisk alumnus and biotech innovator – a veteran leader in obesity biology with deep experience in metabolic hormone pathways, target validation, and first-in-class therapeutics development.","length":223,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":7...